MedTrace Logo

Evaluation of Drug Spread in Ultrasound-Guided Erector Spina Plane Block With Fluoroscopy

NCT05114200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-11-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the injectate spread in erector spinae plane blocks under fluoroscopy.

Conditions

Interventions

PROCEDURE

Erector spinae plane block

Patients will be placed in prone position. Mild sedation will be achieved by using 1-2 mg of midazolam and 50-75 µg of fentanyl iv. The application area will be visualized with General Electrics (GE) Logiq e Ultrasound device using 10-12 MHz linear probe or convex probe. Transverse process and erector spinae muscles will be visualised at the target vertebral level. Following local anesthesia (1-2 cc 2% lidocaine) application to the insertion site, a 20 gauge spinal needle will be inserted using the "in-plane" technique. The needle will be advanced up to the transverse process under ultrasound guidance. After confirming needle position with hydrodissection, 40 mg triamcinolone, 10 cc 0,5% bupivacaine, 10 cc radiopaque contrast agent solution will be injected. Imaging will performed in AP and lateral positions with fluoroscopy immediately and 30 minutes after the injection to evaluate intectate spread.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Halil Cetingok, Ass. Prof. · Istanbul University Istanbul faculty of medicine department of pain medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05114200 on ClinicalTrials.gov